1. From April 24, 2017 to March 7, 2019, the Defendant’s KRW 9620,000 to the Plaintiff and the following.

1. Basic facts

A. As of March 12, 199, the Plaintiff entered into a C Insurance Contract (hereinafter “C Insurance Contract”) with the Defendant as of December 31, 2001, D Insurance Contract as of December 31, 2001 (hereinafter “B Insurance Contract”), and E as of November 5, 2004 (hereinafter “Third Insurance Contract”).

(2) At the time of conclusion of the 1 insurance contract, each of the above insurance contracts included surgery allowances, hospitalization allowances, long-term illness funds, health recovery funds (each insurance contract amount to KRW 20 million), and cancer hospitalization allowances, cancer period funds, cancer health recovery funds (each insurance contract amount to KRW 10 million), etc. according to the terms and conditions of the 2 insurance contract (hereinafter referred to as the "terms and conditions of cancer treatment"), and the details of the 2 insurance contract include: (a) cancer surgery allowances, cancer hospitalization allowances (each insurance contract amount to KRW 20 million) according to the defendant's non-dividend New Cancer Clause (hereinafter referred to as the "terms and conditions of the 2 insurance contract"); (b) the defendant's insurance contract terms and conditions of the operation guarantee (hereinafter referred to as the "terms and conditions of the operation guarantee"); and (c) the defendant's insurance policy amount to KRW 20 million according to the defendant's non-dividend operation guarantee agreement (hereinafter referred to as the "terms and conditions of the insurance contract"); and (d) the defendant's insurance policy amount to be included.

B. On May 26, 2016, the Plaintiff was diagnosed as the left-hand basin cancer and received hospitalized treatment between June 2, 2016 and November 27, 2016 at the F Hospital and G Hospital for a total of 176 days.

During the period of hospitalized treatment, the Plaintiff undergone an anti-explosion (mathy removal operation) on June 7, 2016. From June 8, 2016 to November 7, 2016, the Plaintiff received a total of eight anti-explosion treatment at intervals of about three weeks during the period from June 8, 2016 to November 7, 2016. From December 2, 2016 to January 13, 2017, the period of hospitalized treatment.